PreciThera, Inc.

📍 Montreal, Canada🗓 Founded 2016👥 4 employees💰 Last funded Dec 2019
Biotechnology🌐 precithera.com
Website LinkedIn
PreciThera, Inc. is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The company focuses on heterogeneous genetic disorders that primarily manifest in bone dysfunction. In depth understanding of disease mechanism will allow PreciThera’s targeted strategies to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues found in these patients
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in PreciThera, Inc.?
PreciThera, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did PreciThera, Inc. last raise funding?
The most recent investment in PreciThera, Inc. recorded on gritt.io was in December 2019.
When was PreciThera, Inc. founded?
PreciThera, Inc. was founded in 2016.
What industry is PreciThera, Inc. in?
PreciThera, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is PreciThera, Inc. based?
PreciThera, Inc. is headquartered in Montreal, Canada.